About Ruth
Ruth Barrett has 25 years of experience in technology transfer, commercial healthcare and biopharma. Her expertise spans scientific research, intellectual property (IP) management and licensing, negotiation, business development, fundraising, company creation, corporate governance as both an observer and Non-Executive Director and project and alliance management. Ruth holds a PhD from the University of Cambridge and a Master of Arts (MA) from the University of Oxford.
Ruth leads the relationship between the University of Oxford and Cancer Research Horizons, identifying and de-risking Cancer Research UK (CRUK)-funded intellectual property owned by Oxford and supporting its translation towards patient benefit.
Before joining Cancer Research Horizons, Ruth was Associate Director of Operations at OxSonics, an Oxford-based medical technology oncology spin-out. Prior to this, she was Senior Licensing and Ventures Manager at Oxford University Innovation, the University of Oxford’s technology transfer office (TTO). In this role, she worked on numerous spin-out projects, including the creation of EvOx Therapeutics, Osler Diagnostics, PepGen and GyreOx. She also completed a wide range of licensing, option and material transfer transactions.
Earlier in her career, Ruth was a Business Development Consultant at PharmaVentures, focusing on mergers and acquisitions (M&A) in active pharmaceutical ingredient (API) manufacturing and a Senior Scientist in drug discovery at Daniolabs, a University of Cambridge spin-out.